tirofiban 12.5mg/250ml infusion bags
kent pharma (uk) ltd - tirofiban - infusion - 50microgram/1ml
tirofiban hydrochloride injection
amdipharm limited - tirofiban hydrochloride (unii: 6h925f8o5j) (tirofiban - unii:ggx234si5h) -
tirostat tirofiban (as hydrochloride) 12.5mg/50ml concentrated injection for infusion vial
juno pharmaceuticals pty ltd - tirofiban hydrochloride -
aggrastat (250mcg/ml) concentrate for solution for infusion
correvio (uk) limited - tirofiban - concentrate for solution for infusion - tirofiban 4 µg/ml - antithrombotic agents
ibuprofen/pseudoephedrine hydrochloride 200/30 milligram film coated tablet
mcneil healthcare (ireland) ltd - ibuprofen, pseudoephedrine hydrochloride - film coated tablet - 200/30 milligram - other cold preparations
aggrastat concentrate for soln for inf 250mcg/ml
correvio 15 rue du bicentenaire, 92800 puteaux, france - tirofiban - concentrate for solution for infusion - tirofiban 250 µg/ml - antithrombotic agents
advil cold & flu relief soft capsules ibuprofen 200mg pseudoephedrine hydrochloride 30mg
haleon ireland limited - ibuprofen; pseudoephedrine hydrochloride - capsule, soft - 200 mg/30 milligram(s) - propionic acid derivatives; ibuprofen, combinations
ribofan 12.5mg/50ml concentrate solution for solution for infusion
ms pharma- jordan king abdullah (ii) bin al-hussein industrial - tirofiban hydrochloride monohydrate - solution for infusion - each 50ml vial contains: 12.5 mg of tirofiban - tirofiban
aggrastat
tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate - solution for infusion - tirofiban as hydrochloride monohydrate 0.05 mg/ml - tirofiban - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.
aggrastat 0.25 mg/ml inf. sol. (conc.) i.v. vial
correvio - tirofiban hydrochloride 281 µg/ml - eq. tirofiban 250 µg/ml - concentrate for solution for infusion - 0,25 mg/ml - tirofiban hydrochloride 281 µg/ml - tirofiban